Enapotamab Vedotin represents the exciting breakthrough in personalized tumor therapy. This conjugate utilizes a distinct strategy, targeting AXL target, that becomes elevated in different forms of malignancies. With https://www.targetmol.com/compound/enapotamab_vedotin